Clinic
Wake Forest University Health Sciences
Wake Forest University Health Sciences was paid $187.98M by Medicaid between Jan 2018 and Dec 2024, across 470 billing codes. Its largest line is 99199, Unlisted special service, procedure or report — 13% of everything it billed.
33Billing provider infoWAKE FOREST UNIVERSITY HEALTH SCIENCES
WINSTON SALEM, NC 27157
WINSTON SALEM, NC 27157
33aNPI1003803032assigned 10/04/2005
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$187.98M
24GClaims7,289,003
24DCodes billed470
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in North Carolina
Rank by total paid#1 of 69
Median peer was paid$333K
This provider vs. median564×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 440,244 | $17.04M | |
| 2019 | 494,189 | $20.77M | |
| 2020 | 397,445 | $16.67M | |
| 2021 | 1,019,073 | $26.94M | |
| 2022 | 1,711,968 | $37.42M | |
| 2023 | 1,753,575 | $37.34M | |
| 2024incomplete | 1,472,509 | $31.82M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99199 | Unlisted special service, procedure or report | 13% | 3,478,597 | 1,895,990 | $23.81M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 505,014 | 422,036 | $23.69M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 386,435 | 330,716 | $23.69M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.1% | 151,543 | 134,052 | $17.19M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.9% | 191,294 | 165,955 | $16.73M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.7% | 61,048 | 51,007 | $5.03M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.6% | 111,339 | 42,474 | $4.87M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.2% | 88,064 | 74,962 | $4.18M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.2% | 63,505 | 53,079 | $4.08M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.8% | 39,901 | 33,538 | $3.43M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.8% | 37,056 | 32,702 | $3.38M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.5% | 42,961 | 16,761 | $2.74M |
458 more codes
| 99244 | Office or other outpatient consultation, moderate to high complexity | 1.3% | 18,888 | $2.42M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.3% | 26,898 | $2.40M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.2% | 123,198 | $2.28M |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.1% | 63,469 | $2.13M |
| 99204 | Doctor's office visit, new patient (more involved) | 1.1% | 22,182 | $2.08M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 32,548 | $1.54M |
| 99479 | Subsequent intensive care, per day, very low birth weight infant | <1% | 15,775 | $1.52M |
| 99472 | Subsequent inpatient pediatric critical care, per day, 2-5 years | <1% | 5,095 | $1.38M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 14,103 | $1.36M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 30,552 | $1.36M |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | <1% | 7,688 | $1.29M |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 21,925 | $1.27M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 31,486 | $1.26M |
| 99417 | Prolong home eval add 15m | <1% | 5,539 | $1.25M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 23,263 | $1.23M |
| 99223 | Prolong inpt eval add15 m | <1% | 9,470 | $1.13M |
| 99460 | <1% | 14,872 | $1.12M | |
| 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | <1% | 3,344 | $984K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 36,476 | $949K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 26,832 | $892K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 9,343 | $883K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 174,664 | $822K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 9,755 | $711K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 4,855 | $675K |
| 71045 | Radiologic examination, chest; single view | <1% | 115,017 | $670K |
| 95720 | <1% | 4,569 | $661K | |
| 96127 | <1% | 132,864 | $565K | |
| 99480 | Subsequent intensive care, per day, low birth weight infant | <1% | 6,122 | $555K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 13,528 | $554K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 9,098 | $553K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 41,623 | $551K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 42,334 | $536K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 16,120 | $518K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 66,254 | $517K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 6,575 | $503K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 60,039 | $500K |
| 99205 | Prolong outpt/office vis | <1% | 4,012 | $487K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 13,123 | $442K |
| 99243 | <1% | 5,300 | $439K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 5,826 | $426K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 17,038 | $413K |
| 95951 | <1% | 2,072 | $398K | |
| 01922 | <1% | 3,662 | $389K | |
| 88307 | <1% | 6,116 | $363K | |
| 74018 | <1% | 54,917 | $360K | |
| 76770 | <1% | 12,399 | $333K | |
| S0620 | Routine ophthalmological examination including refraction; new patient | <1% | 5,408 | $316K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 12,035 | $316K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 8,800 | $297K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 5,452 | $234K |
| 99245 | <1% | 1,610 | $234K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 4,006 | $230K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 2,663 | $226K |
| 99254 | <1% | 1,893 | $221K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 2,029 | $203K |
| 92060 | <1% | 8,699 | $196K | |
| D1206 | Topical application of fluoride varnish | <1% | 13,144 | $195K |
| S0280 | Medical home program, comprehensive care coordination and planning, initial plan | <1% | 4,011 | $182K |
| 93320 | <1% | 9,192 | $174K | |
| 90474 | <1% | 9,074 | $171K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 7,465 | $161K |
| 93970 | <1% | 2,958 | $160K | |
| 54300 | <1% | 303 | $155K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 2,902 | $154K |
| 97803 | <1% | 4,063 | $154K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 6,334 | $153K |
| 99462 | <1% | 4,567 | $150K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,135 | $149K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 8,256 | $146K |
| S0281 | Medical home program, comprehensive care coordination and planning, maintenance of plan | <1% | 1,227 | $145K |
| 77014 | <1% | 5,799 | $144K | |
| 93975 | <1% | 2,116 | $135K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 923 | $132K |
| 90837 | Psychotherapy session, about an hour | <1% | 1,934 | $126K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 2,485 | $125K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,345 | $115K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 3,276 | $113K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 3,137 | $111K |
| 93325 | <1% | 12,710 | $110K | |
| 73630 | <1% | 15,468 | $110K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 2,234 | $108K |
| 99255 | <1% | 733 | $105K | |
| 54150 | <1% | 843 | $103K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 2,141 | $100K |
| 74230 | <1% | 4,889 | $98K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 2,689 | $97K |
| 86077 | <1% | 3,018 | $96K | |
| 76825 | <1% | 1,008 | $96K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 1,020 | $95K |
| 96130 | <1% | 1,369 | $95K | |
| 14040 | <1% | 455 | $93K | |
| 64644 | <1% | 1,316 | $92K | |
| 54161 | <1% | 465 | $92K | |
| 99442 | <1% | 2,437 | $90K | |
| 59025 | Fetal non-stress test | <1% | 4,520 | $89K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 4,924 | $84K |
| 99443 | <1% | 1,610 | $78K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 1,513 | $75K |
| 74022 | <1% | 5,987 | $73K | |
| 99401 | <1% | 3,012 | $73K | |
| 76820 | <1% | 3,907 | $72K | |
| 83020 | <1% | 5,682 | $70K | |
| 92134 | <1% | 6,667 | $68K | |
| 73610 | <1% | 10,373 | $63K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,548 | $62K |
| 76506 | <1% | 2,565 | $62K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 2,005 | $61K |
| 73562 | <1% | 9,380 | $60K | |
| 20610 | <1% | 2,134 | $56K | |
| 93971 | <1% | 1,499 | $54K | |
| 54360 | <1% | 113 | $53K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,002 | $53K |
| 71250 | <1% | 1,742 | $51K | |
| 70498 | <1% | 944 | $51K | |
| 81025 | <1% | 7,640 | $49K | |
| 59410 | <1% | 72 | $49K | |
| S0621 | Routine ophthalmological examination including refraction; established patient | <1% | 784 | $48K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 2,266 | $47K |
| 99242 | <1% | 782 | $45K | |
| 73130 | <1% | 7,124 | $45K | |
| 95816 | <1% | 1,259 | $45K | |
| 64645 | <1% | 772 | $44K | |
| 92015 | Determination of refractive state | <1% | 6,471 | $44K |
| 84165 | <1% | 4,981 | $43K | |
| 73590 | <1% | 6,655 | $42K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,482 | $41K |
| 73030 | <1% | 6,685 | $40K | |
| 96131 | <1% | 615 | $39K | |
| 73090 | <1% | 6,342 | $38K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 630 | $36K |
| 76801 | <1% | 779 | $36K | |
| 97802 | <1% | 674 | $36K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,131 | $35K |
| 72082 | <1% | 2,651 | $34K | |
| 59515 | <1% | 44 | $33K | |
| 76827 | <1% | 990 | $32K | |
| 88108 | <1% | 1,791 | $32K | |
| 90686 | <1% | 50,341 | $32K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 545 | $32K |
| 88141 | <1% | 1,731 | $32K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 1,892 | $31K |
| 99220 | <1% | 299 | $31K | |
| 73521 | <1% | 3,373 | $31K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 238 | $30K |
| 93248 | <1% | 2,113 | $30K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 1,277 | $30K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 784 | $29K |
| 95718 | <1% | 300 | $28K | |
| 00731 | <1% | 293 | $28K | |
| 87210 | <1% | 7,373 | $28K | |
| 55175 | <1% | 215 | $28K | |
| 99464 | <1% | 462 | $27K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,584 | $27K |
| 99253 | <1% | 355 | $25K | |
| 73110 | <1% | 3,688 | $24K | |
| 97597 | <1% | 1,519 | $23K | |
| 73552 | <1% | 3,385 | $23K | |
| 01961 | <1% | 220 | $23K | |
| 73502 | <1% | 3,385 | $22K | |
| 73560 | <1% | 3,515 | $21K | |
| 86334 | <1% | 2,316 | $20K | |
| 91122 | <1% | 300 | $20K | |
| 99051 | <1% | 798 | $20K | |
| 88112 | <1% | 626 | $20K | |
| 90870 | <1% | 321 | $20K | |
| 73070 | <1% | 3,447 | $20K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 415 | $19K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 29 | $19K |
| 72100 | <1% | 2,702 | $19K | |
| 62370 | <1% | 1,116 | $19K | |
| 88300 | <1% | 6,393 | $19K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 95 | $19K |
| 95873 | <1% | 1,423 | $18K | |
| 88304 | <1% | 2,479 | $18K | |
| 88342 | <1% | 650 | $18K | |
| 95251 | <1% | 669 | $18K | |
| 94010 | <1% | 2,917 | $17K | |
| 0071A | <1% | 388 | $17K | |
| 69210 | <1% | 527 | $17K | |
| 00920 | <1% | 199 | $17K | |
| 0072A | <1% | 309 | $17K | |
| 83655 | <1% | 1,476 | $17K | |
| 99156 | <1% | 278 | $16K | |
| 77427 | <1% | 152 | $16K | |
| 51798 | <1% | 1,718 | $15K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 6,215 | $15K |
| 72170 | <1% | 2,839 | $15K | |
| 76830 | Ultrasound, transvaginal | <1% | 257 | $15K |
| 95819 | <1% | 395 | $15K | |
| 90651 | <1% | 2,981 | $14K | |
| 93244 | <1% | 898 | $14K | |
| 99478 | <1% | 126 | $14K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 330 | $14K |
| 0001A | <1% | 289 | $14K | |
| 20605 | <1% | 663 | $13K | |
| 99157 | <1% | 157 | $13K | |
| 29450 | <1% | 118 | $13K | |
| 96112 | <1% | 122 | $13K | |
| 92567 | <1% | 1,140 | $12K | |
| 99441 | <1% | 588 | $12K | |
| 93000 | <1% | 1,116 | $12K | |
| 95782 | <1% | 137 | $12K | |
| 93296 | <1% | 1,115 | $12K | |
| 93886 | <1% | 301 | $11K | |
| 88313 | <1% | 1,164 | $11K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 451 | $11K |
| 88173 | <1% | 326 | $11K | |
| 88350 | <1% | 206 | $11K | |
| 99381 | <1% | 128 | $11K | |
| 73080 | <1% | 1,593 | $10K | |
| 72132 | <1% | 249 | $10K | |
| 94060 | <1% | 812 | $10K | |
| 90734 | <1% | 2,974 | $10K | |
| 51741 | <1% | 216 | $9K | |
| 72129 | <1% | 239 | $9K | |
| 95811 | <1% | 44 | $9K | |
| 73100 | <1% | 1,466 | $9K | |
| 87807 | <1% | 704 | $9K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 297 | $9K |
| 96040 | <1% | 313 | $9K | |
| 76813 | <1% | 200 | $9K | |
| 0002A | <1% | 167 | $8K | |
| 99217 | <1% | 211 | $8K | |
| 95800 | <1% | 174 | $8K | |
| 93227 | <1% | 443 | $7K | |
| 99221 | <1% | 98 | $7K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,918 | $7K |
| 73060 | <1% | 1,126 | $7K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 74 | $7K |
| 99219 | <1% | 57 | $7K | |
| 99354 | <1% | 60 | $7K | |
| 99499 | <1% | 56 | $7K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 101 | $6K |
| 93295 | <1% | 310 | $6K | |
| 93294 | <1% | 542 | $6K | |
| 96161 | <1% | 2,423 | $6K | |
| 95886 | <1% | 125 | $6K | |
| 73140 | <1% | 808 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,100 | $6K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 25 | $5K |
| 99173 | <1% | 64,119 | $5K | |
| 72040 | <1% | 685 | $5K | |
| 70491 | <1% | 107 | $5K | |
| 85097 | <1% | 189 | $5K | |
| 88291 | <1% | 281 | $5K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 141 | $5K |
| 99152 | <1% | 742 | $5K | |
| 76885 | <1% | 164 | $5K | |
| 94729 | <1% | 833 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 611 | $5K |
| 88311 | <1% | 636 | $4K | |
| 90480 | <1% | 93 | $4K | |
| 01991 | <1% | 122 | $4K | |
| 00635 | <1% | 49 | $4K | |
| 96133 | <1% | 20 | $4K | |
| 92557 | <1% | 202 | $4K | |
| 11721 | <1% | 600 | $4K | |
| 92551 | <1% | 57,675 | $4K | |
| 51600 | <1% | 119 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 409 | $4K |
| 93922 | <1% | 141 | $4K | |
| 88189 | <1% | 60 | $4K | |
| Q0112 | All potassium hydroxide (koh) preparations | <1% | 750 | $4K |
| 96137 | <1% | 44 | $4K | |
| 74019 | <1% | 418 | $4K | |
| 92250 | <1% | 176 | $4K | |
| 85018 | <1% | 5,857 | $4K | |
| 90966 | <1% | 178 | $4K | |
| 96132 | <1% | 36 | $3K | |
| 96450 | <1% | 49 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 231 | $3K |
| 77072 | <1% | 459 | $3K | |
| 88346 | <1% | 206 | $3K | |
| 92083 | <1% | 244 | $3K | |
| 99100 | <1% | 250 | $3K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 751 | $3K |
| 99477 | <1% | 12 | $3K | |
| 81000 | <1% | 1,006 | $3K | |
| 36224 | <1% | 18 | $3K | |
| 99383 | <1% | 29 | $3K | |
| 81003 | <1% | 2,281 | $3K | |
| 96160 | <1% | 998 | $3K | |
| 95117 | <1% | 443 | $3K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 100 | $3K |
| 85060 | <1% | 216 | $3K | |
| 99385 | <1% | 34 | $3K | |
| 93018 | <1% | 367 | $3K | |
| 96136 | <1% | 179 | $3K | |
| 70496 | <1% | 56 | $3K | |
| 96101 | <1% | 77 | $3K | |
| 91120 | <1% | 62 | $2K | |
| 88341 | <1% | 64 | $2K | |
| 17311 | <1% | 17 | $2K | |
| 81002 | <1% | 1,800 | $2K | |
| 30901 | <1% | 30 | $2K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 157 | $2K |
| 88348 | <1% | 95 | $2K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 26 | $2K |
| 70486 | <1% | 55 | $2K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 52 | $2K |
| 77300 | <1% | 33 | $2K | |
| 97161 | <1% | 41 | $2K | |
| 95115 | <1% | 327 | $2K | |
| 76870 | <1% | 77 | $2K | |
| 94726 | <1% | 295 | $2K | |
| 73620 | <1% | 172 | $2K | |
| 99226 | <1% | 51 | $2K | |
| 72110 | <1% | 137 | $2K | |
| 92133 | <1% | 165 | $2K | |
| 36226 | <1% | 16 | $2K | |
| 99241 | <1% | 42 | $2K | |
| 77334 | <1% | 30 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 295 | $2K |
| 96156 | <1% | 24 | $2K | |
| 72081 | <1% | 159 | $2K | |
| 90715 | <1% | 684 | $2K | |
| 96113 | <1% | 19 | $1K | |
| 90620 | <1% | 350 | $1K | |
| 90836 | <1% | 54 | $1K | |
| 99407 | <1% | 134 | $1K | |
| 80047 | <1% | 79 | $1K | |
| 74455 | <1% | 101 | $1K | |
| 81001 | <1% | 650 | $1K | |
| 99251 | <1% | 36 | $1K | |
| 17110 | <1% | 29 | $1K | |
| 99382 | <1% | 12 | $1K | |
| 82950 | <1% | 242 | $1K | |
| 90670 | <1% | 24,469 | $1K | |
| 77263 | <1% | 14 | $1K | |
| 90656 | <1% | 2,136 | $1K | |
| 87631 | <1% | 245 | $1K | |
| 88302 | <1% | 200 | $1K | |
| 99140 | <1% | 605 | $1K | |
| 73600 | <1% | 181 | $1K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 61 | $1K |
| 93923 | <1% | 38 | $1K | |
| 0111A | <1% | 19 | $1K | |
| 64643 | <1% | 39 | $1K | |
| 80500 | <1% | 75 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 41 | $1K |
| 99153 | Mod sedat endo service >5yrs | <1% | 184 | $1K |
| 95250 | <1% | 26 | $981.04 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 83 | $970.58 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 44 | $966.51 |
| 95909 | <1% | 15 | $917.72 | |
| 99252 | <1% | 12 | $909.32 | |
| 99459 | <1% | 93 | $907.65 | |
| 11102 | <1% | 30 | $856.94 | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 29 | $840.39 |
| 90633 | <1% | 6,288 | $834.39 | |
| 64615 | <1% | 14 | $828.18 | |
| 80053 | Comprehensive metabolic panel | <1% | 102 | $813.16 |
| 99454 | <1% | 19 | $803.87 | |
| 72070 | <1% | 114 | $800.93 | |
| 99406 | <1% | 68 | $789.08 | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 15 | $784.43 |
| 82947 | <1% | 224 | $749.46 | |
| 90697 | <1% | 1,544 | $703.85 | |
| 91065 | <1% | 89 | $697.67 | |
| 97162 | <1% | 28 | $680.02 | |
| 77295 | <1% | 12 | $657.85 | |
| 76642 | <1% | 27 | $654.09 | |
| 93246 | <1% | 106 | $618.35 | |
| 31231 | <1% | 12 | $594.18 | |
| 84166 | <1% | 75 | $573.94 | |
| 90677 | <1% | 1,615 | $572.82 | |
| 95812 | <1% | 15 | $568.56 | |
| 27096 | <1% | 14 | $554.74 | |
| 00142 | <1% | 12 | $549.48 | |
| 90723 | <1% | 13,385 | $540.15 | |
| 76937 | <1% | 81 | $497.99 | |
| 96380 | <1% | 36 | $497.06 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 72 | $485.73 |
| 70250 | <1% | 50 | $483.45 | |
| 93308 | <1% | 29 | $473.71 | |
| 90680 | <1% | 8,249 | $466.53 | |
| 99224 | <1% | 22 | $458.78 | |
| 93880 | <1% | 14 | $427.97 | |
| 31575 | <1% | 13 | $420.80 | |
| 94690 | <1% | 15 | $397.71 | |
| 93298 | <1% | 28 | $360.09 | |
| G0452 | Molecular pathology procedure; physician interpretation and report | <1% | 289 | $325.34 |
| 70360 | <1% | 44 | $288.95 | |
| 92579 | <1% | 12 | $274.92 | |
| 73120 | <1% | 42 | $269.93 | |
| 74420 | <1% | 25 | $263.61 | |
| 0298T | <1% | 92 | $241.36 | |
| 95874 | <1% | 43 | $236.56 | |
| 73565 | <1% | 34 | $232.32 | |
| 90647 | <1% | 13,051 | $230.51 | |
| 92201 | <1% | 858 | $225.91 | |
| 93280 | <1% | 16 | $217.40 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,607 | $198.09 |
| 77073 | <1% | 19 | $190.71 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 41 | $188.58 |
| 93990 | <1% | 13 | $180.46 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 31 | $162.62 |
| 77002 | <1% | 12 | $154.39 | |
| 90785 | <1% | 64 | $149.43 | |
| 93356 | <1% | 171 | $140.75 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 55 | $129.29 |
| 92587 | <1% | 561 | $117.72 | |
| 93242 | <1% | 22 | $113.10 | |
| 90688 | <1% | 137 | $94.80 | |
| 94618 | <1% | 15 | $87.64 | |
| 94664 | <1% | 33 | $66.72 | |
| 76000 | <1% | 12 | $61.15 | |
| 96381 | <1% | 14 | $59.20 | |
| 93290 | <1% | 13 | $53.49 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 89 | $49.42 |
| 11719 | <1% | 16 | $5.44 | |
| 93297 | <1% | 13 | $4.21 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 40 | $3.38 |
| 94760 | <1% | 13 | $2.07 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 14 | $1.52 |
| 99024 | 0% | 6,930 | $0.00 | |
| 0500F | 0% | 208 | $0.00 | |
| 90696 | 0% | 759 | $0.00 | |
| 3008F | 0% | 689 | $0.00 | |
| 90716 | 0% | 641 | $0.00 | |
| 36416 | 0% | 681 | $0.00 | |
| 92558 | 0% | 66 | $0.00 | |
| 90744 | 0% | 31 | $0.00 | |
| 3074F | 0% | 387 | $0.00 | |
| D0120 | Dental checkup, returning patient | 0% | 49 | $0.00 |
| 90698 | 0% | 194 | $0.00 | |
| 1125F | 0% | 12 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 253 | $0.00 |
| 91307 | 0% | 66 | $0.00 | |
| 98967 | 0% | 26 | $0.00 | |
| 3351F | 0% | 64 | $0.00 | |
| D9420 | 0% | 20 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 15 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 26 | $0.00 |
| 90381 | 0% | 30 | $0.00 | |
| 89342 | 0% | 19 | $0.00 | |
| 90710 | 0% | 1,926 | $0.00 | |
| 3078F | 0% | 501 | $0.00 | |
| 90707 | 0% | 612 | $0.00 | |
| 1159F | 0% | 2,444 | $0.00 | |
| 84481 | 0% | 456 | $0.00 | |
| 1160F | 0% | 2,446 | $0.00 | |
| 90681 | 0% | 1,181 | $0.00 | |
| 98968 | 0% | 83 | $0.00 | |
| 90685 | 0% | 522 | $0.00 | |
| 82010 | 0% | 454 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 135 | $0.00 |
| 81206 | 0% | 17 | $0.00 | |
| 90700 | 0% | 221 | $0.00 | |
| 91311 | 0% | 38 | $0.00 | |
| 99072 | 0% | 81 | $0.00 | |
| 90380 | 0% | 16 | $0.00 | |
| 91308 | 0% | 23 | $0.00 | |
| 90691 | 0% | 15 | $0.00 | |
| D1120 | Dental cleaning, child | 0% | 13 | $0.00 |
| D1110 | Prophylaxis - adult | 0% | 21 | $0.00 |
| D0220 | Intraoral - periapical first radiographic image | 0% | 15 | $0.00 |
| 3288F | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZAAS, DAVID (PRESIDENT, AH WFB)
| Provider | Location | Paid |
|---|---|---|
| Wake Forest University Health Sciences | Winston Salem, NC | $4.10M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.